Cargando…
Effluent Markers Related to Epithelial Mesenchymal Transition with Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients
Objectives. Epithelial mesenchymal transition (EMT) is important for peritoneal deterioration. We evaluated the association between peritoneal solute transport rate (PSTR) and effluent markers related to EMT with adjusted values for effluent cancer antigen 125 (CA125). Methods. One hundred five inci...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132654/ https://www.ncbi.nlm.nih.gov/pubmed/21755056 http://dx.doi.org/10.4061/2011/261040 |
_version_ | 1782207850555113472 |
---|---|
author | Mizuiri, Sonoo Hemmi, Hiromichi Arita, Michitsune Tai, Reibin Hattori, Yoshinari Muto, Atsuhiko Suzuki, Yasunori Ohashi, Yasushi Sakai, Ken Aikawa, Atsushi |
author_facet | Mizuiri, Sonoo Hemmi, Hiromichi Arita, Michitsune Tai, Reibin Hattori, Yoshinari Muto, Atsuhiko Suzuki, Yasunori Ohashi, Yasushi Sakai, Ken Aikawa, Atsushi |
author_sort | Mizuiri, Sonoo |
collection | PubMed |
description | Objectives. Epithelial mesenchymal transition (EMT) is important for peritoneal deterioration. We evaluated the association between peritoneal solute transport rate (PSTR) and effluent markers related to EMT with adjusted values for effluent cancer antigen 125 (CA125). Methods. One hundred five incident peritoneal dialysis (PD) patients on PD for 25 (12–68) months with biocompatible solutions were included in the study. Fast peritoneal equilibration test was used to evaluate PSTR. Effluent hepatocyte growth factor (HGF), bone morphogenic protein-7 (BMP-7), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and CA125 at 4 h were measured. Results. Patients with dialysate/plasma creatinine ≧0.82 showed significantly higher effluent HGF (240 versus 133 pg/mL, P < .001), VEGF, IL-6, and IL6/CA125 levels than the others but no significant differences in effluent HGF/CA125, BMP-7, and BMP7/CA125 were observed. Conclusion. Increase in the effluent HGF levels as a compensatory mechanism is a marker of peritoneal deterioration, but controversy remains regarding adjusted value for CA125. |
format | Online Article Text |
id | pubmed-3132654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | SAGE-Hindawi Access to Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-31326542011-07-13 Effluent Markers Related to Epithelial Mesenchymal Transition with Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients Mizuiri, Sonoo Hemmi, Hiromichi Arita, Michitsune Tai, Reibin Hattori, Yoshinari Muto, Atsuhiko Suzuki, Yasunori Ohashi, Yasushi Sakai, Ken Aikawa, Atsushi Int J Nephrol Clinical Study Objectives. Epithelial mesenchymal transition (EMT) is important for peritoneal deterioration. We evaluated the association between peritoneal solute transport rate (PSTR) and effluent markers related to EMT with adjusted values for effluent cancer antigen 125 (CA125). Methods. One hundred five incident peritoneal dialysis (PD) patients on PD for 25 (12–68) months with biocompatible solutions were included in the study. Fast peritoneal equilibration test was used to evaluate PSTR. Effluent hepatocyte growth factor (HGF), bone morphogenic protein-7 (BMP-7), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and CA125 at 4 h were measured. Results. Patients with dialysate/plasma creatinine ≧0.82 showed significantly higher effluent HGF (240 versus 133 pg/mL, P < .001), VEGF, IL-6, and IL6/CA125 levels than the others but no significant differences in effluent HGF/CA125, BMP-7, and BMP7/CA125 were observed. Conclusion. Increase in the effluent HGF levels as a compensatory mechanism is a marker of peritoneal deterioration, but controversy remains regarding adjusted value for CA125. SAGE-Hindawi Access to Research 2011-07-06 /pmc/articles/PMC3132654/ /pubmed/21755056 http://dx.doi.org/10.4061/2011/261040 Text en Copyright © 2011 Sonoo Mizuiri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Mizuiri, Sonoo Hemmi, Hiromichi Arita, Michitsune Tai, Reibin Hattori, Yoshinari Muto, Atsuhiko Suzuki, Yasunori Ohashi, Yasushi Sakai, Ken Aikawa, Atsushi Effluent Markers Related to Epithelial Mesenchymal Transition with Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients |
title | Effluent Markers Related to Epithelial Mesenchymal Transition with
Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients |
title_full | Effluent Markers Related to Epithelial Mesenchymal Transition with
Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients |
title_fullStr | Effluent Markers Related to Epithelial Mesenchymal Transition with
Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients |
title_full_unstemmed | Effluent Markers Related to Epithelial Mesenchymal Transition with
Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients |
title_short | Effluent Markers Related to Epithelial Mesenchymal Transition with
Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients |
title_sort | effluent markers related to epithelial mesenchymal transition with
adjusted values for effluent cancer antigen 125 in peritoneal dialysis patients |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132654/ https://www.ncbi.nlm.nih.gov/pubmed/21755056 http://dx.doi.org/10.4061/2011/261040 |
work_keys_str_mv | AT mizuirisonoo effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT hemmihiromichi effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT aritamichitsune effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT taireibin effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT hattoriyoshinari effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT mutoatsuhiko effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT suzukiyasunori effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT ohashiyasushi effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT sakaiken effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients AT aikawaatsushi effluentmarkersrelatedtoepithelialmesenchymaltransitionwithadjustedvaluesforeffluentcancerantigen125inperitonealdialysispatients |